drugset / Trial / NCT05273398

Effects of Diazepam on RNS Detections

NCT05273398

Phase 4 Completed 4 enrolled University of Cincinnati
NaSingle-groupOpen-labelDiagnostic

Summary

To assess the magnitude and duration of reduction in RNS recorded Detections and Long Episodes following intranasal administration of Valtoco®. All participants will have been implanted and treated with an RNS system for clinical purposes and regularly upload Detection and Long Episode data on a regular basis as part of regular clinical treatment. Participants will come to the clinic and be administered a single dose of Valtoco® via nasal spray. RNS recorded Detections and Long Episodes before and after Valtoco® administration will be compared. This is a pilot study, so all outcomes are exploratory.

Timeline

Start
2022-03-01
Primary completion
2022-11-10
Completion
2022-11-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Diazepam Small molecule Intranasal

Indications